Osmetech plc Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Osmetech plc's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Contents

• 1 List of Tables
  • 1.2 List of Figures
• 2 Company Snapshot
  • 2.1 Key Information
  • 2.2 Company Overview
  • 2.3 Financial Performance
  • 2.4 Industry Outlook - In Vitro Diagnostics
• 3 Business Description
  • 3.1 Business Overview
  • 3.2 Major Products and Services
    • 3.2.1 Overview
• 4 History
• 5 Key Employees
• 6 Key Employee Biographies
• 7 Company Statement
• 8 Locations And Subsidiaries
  • 8.1 Head Office
• 9 Recent Developments
  • 9.1 Financial Announcements
    • 9.1.1 Mar 28, 2008: Osmetech Reports Preliminary 2007 Results
    • 9.1.2 Sep 27, 2007: Osmetech Reports H1 2007 Results
    • 9.1.3 Mar 20, 2007: Osmetech Reports 2006 Results
  • 9.2 Corporate Communications
    • 9.2.1 Aug 12, 2008: Osmetech Announces Board Changes
    • 9.2.2 Feb 14, 2007: Osmetech Appoints Executive Director
  • 9.3 Product News
    • 9.3.1 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
    • 9.3.2 Feb 12, 2008: Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
    • 9.3.3 Feb 12, 2008: Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
    • 9.3.4 Jan 07, 2008: Warfarin Test Submitted for FDA approval
  • 9.4 Product Approvals
    • 9.4.1 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
    • 9.4.2 Jan 07, 2008: Warfarin Test Submitted for FDA approval
• 10 Osmetech plc Pipeline Products
  • 10.1 Osmetech plc Product Pipeline Analysis
    • 10.1.1 Osmetech plc Pipeline Products By Equipment Type
    • 10.1.2 Osmetech plc Pipeline Products By Development Stage
    • 10.1.3 Osmetech plc Pipeline Products By Therapy Area
    • 10.1.4 Osmetech plc Pipeline Products By Clinical Trials
    • 10.1.5 Osmetech plc Pipeline Products By News Summary
  • 10.2 eSensor 2C9/VKOR test
    • 10.2.1 Product Description
    • 10.2.2 Product Status
    • 10.2.3 Clinical Trials
    • 10.2.4 Product Milestone
  • 10.3 eSensor XT-8 System
    • 10.3.1 Product Description
    • 10.3.2 Product Status
    • 10.3.3 Product Milestone
  • 10.4 CYP450/VKOR
    • 10.4.1 Product Description
    • 10.4.2 Product Status
    • 10.4.3 Product Milestone
• 11 Appendix
  • 11.1 Methodology
    • 11.1.1 Coverage
    • 11.1.2 Secondary Research
    • 11.1.3 Primary Research
    • 11.1.4 Expert Panel Validation
  • 11.2 Contact Us
  • 11.3 About Global Markets Direct
  • 11.4 Disclaimer
• 1 List of Tables
  • Table 1: Osmetech plc,Key Facts
  • Table 2: Osmetech plc, Key Employees,
  • Table 3: Osmetech plc Pipeline Products by Equipment Type
  • Table 4: Osmetech plc Pipeline Products By Development Stage
  • Table 5: Osmetech plc Pipeline Products By Therapy Area
  • Table 6: Osmetech plc Pipeline Products By Clinical Trials
  • Table 7: Osmetech plc Pipeline Products By News Summaries
  • 1.2 List of Figures
  • Figure 1: Osmetech plc Pipeline Products By Development Stage
  • Figure 2: Osmetech plc Pipeline Products By News Summary
  • Figure 3: Global Markets Direct Methodology